This Overview has been created by the Life Sciences Asia Pacific Network, of which Corrs is a member. It contains Australia-specific content by Eugenia Kolivos (Partner), Isaac Lin (Special Counsel) & Heather Curd (Senior Associate).
For many years, emerging markets have been strategically important for the growth and development of the Lifesciences sector. Almost 90% of the sector now operates in an emerging market, including the Asia-Pacific region.
The Life Sciences Asia Pacific Network has prepared this guide, which gives a comparative overview of the distribution and marketing of drugs in Australia, China, India, Indonesia, Japan, Korea, Singapore, Taiwan, Thailand and Vietnam. It also highlights the key legal and commercial issues to consider when doing business in the region.
To access a PDF copy of A Comparative overview of Distribution and Marketing of Drugs across Asia-Pacific, click the 'Download' button above.
The content of this article is intended to provide a general guide to the subject matter. Specialist advice should be sought about your specific circumstances.
|Chambers Asia Pacific Awards 2016 Winner
Client Service Award
|Employer of Choice for Gender Equality